My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

OptiNose, Inc. - Common Stock (NQ:OPTN)

9.600 UNCHANGED

Last Price Updated: 4:00 PM EDT, May 20, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about OptiNose, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

December 06, 2023

Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 06, 2023

Via Benzinga

Crude Oil Down 4%; Pharvaris Shares Spike Higher ↗

December 06, 2023

U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,...

Via Benzinga

Topics Stocks

Recap: OptiNose Q1 Earnings ↗

May 11, 2023

Via Benzinga

OptiNose's Return On Capital Employed Insights ↗

March 09, 2023

Via Benzinga

Earnings Preview: OptiNose ↗

March 06, 2023

Via Benzinga

OptiNose: Q2 Earnings Insights ↗

August 11, 2022

OptiNose (NASDAQ:OPTN) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

US Stocks Higher; Private Payrolls Rise By 103,000 In November ↗

December 06, 2023

U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%...

Via Benzinga

Topics Stocks

Why ENT-Focused OptiNose Shares Are Diving Today ↗

December 06, 2023

OptiNose, Inc. (NASDAQ: OPTN) shares are trading lower after the company announced a three-month extension of the FDA review period for the supplemental new drug application for

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 06, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023 ↗

August 21, 2023

Via Benzinga

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Optinose Shared Additional Encouraging Data From Late-Stage Chronic Sinusitis Studies ↗

July 08, 2022

Via Benzinga

Earnings Scheduled For August 10, 2023 ↗

August 10, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

July 28, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

June 07, 2023

On Wednesday, 29 companies set new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 19, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

November 25, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

June 06, 2023

On Tuesday, 69 stocks hit new 52-week lows.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 24, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 21, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 19, 2023

On Friday, 63 companies hit new 52-week lows.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 21, 2022

We're starting the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning!

Via InvestorPlace

Pooled Data Show Optinose's XHANCE Cut Sinusitis Flares By 66% ↗

July 13, 2022

Optinose Inc (NASDAQ: OPTN) announced the results of pre-planned analyses from the ReOpen trial program evaluating XHANCE for chronic sinusitis.

Via Benzinga

Looking Into OptiNose's Return On Capital Employed ↗

June 16, 2022

Benzinga Pro data, OptiNose (NASDAQ:OPTN) reported Q1 sales of $14.76 million. Earnings fell to a loss of $25.33 million, resulting in a 62.14% decrease from last quarter.

Via Benzinga

71 Biggest Movers From Yesterday ↗

June 16, 2022

Gainers Sidus Space, Inc. (NASDAQ: SIDU) shares jumped 225% to close at $4.68 on Wednesday after the company announced it is part of Collins Aerospace team which was awarded NASA's Exploration...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 15, 2022

Via Benzinga

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 13, 2022

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.